CollPlant Biotechnologies (CLGN) Inventory (2017 - 2026)

CollPlant Biotechnologies has reported Inventory for 10 years, with the latest figure at $679000.0 in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 99.9% year-over-year to $679000.0; the trailing twelve-month figure through Mar 2026 stood at $679000.0 (down 99.9% YoY), and the FY2025 full-year result was $573000.0, down 99.87% from the prior year.
• Inventory for Q1 2026 stood at $679000.0, up from $573000.0 in the prior quarter.
• The five-year high for Inventory was $1.5 billion in Q3 2023, with the low at $439000.0 in Q2 2024.
• Historically, Inventory has averaged $322.2 million across 5 years, with a median of $1.5 million in 2022.
• The largest YoY upside for Inventory was 133144.68% in 2023 against a maximum downside of 99.95% in 2023.
• CollPlant Biotechnologies' Inventory stood at $1.4 billion in 2022, then plunged by 99.95% to $714000.0 in 2023, then surged by 61524.65% to $440.0 million in 2024, then tumbled by 99.87% to $573000.0 in 2025, then gained by 18.5% to $679000.0 in 2026.
• The last three Inventory figures came in at $679000.0 (Q1 2026), $573000.0 (Q4 2025), and $553000.0 (Q2 2025), per Business Quant data.